Michelle Glass

country of citizenship: New Zealand

occupation: academic

Michelle Glass is a New Zealand pharmacology academic. She is currently a full professor and Head of the Department of Pharmacology & Toxicology at the University of Otago. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 83

Date

Title

Authors

2020-02-21

Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists

Monica Patel, Samuel Banister, Natasha Grimsey, Michelle Glass, David B Finlay
2020-04-15

Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modelling

Xiao Zhu, David B Finlay, Michelle Glass, Stephen Duffull
2020-02-28

100 years of modelling ligand-receptor binding and response: A focus on GPCRs

David B Finlay, Stephen Duffull, Michelle Glass
2020-10-15

Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA

Jamie J Manning, Marina Santiago, Lewis J Martin, Mark A. Connor, Michelle Glass, Samuel Banister
2020-11-06

Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre

Hunter Robson, Rhiannon Braund, Michelle Glass, Janelle Ashton, Michael Tatley
2019-04-10

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence

David B Finlay, Monica Patel, Michelle Glass, Natasha Grimsey
2019-02-22

An intact model for quantifying functional selectivity

Xiao Zhu, David B Finlay, Michelle Glass, Stephen Duffull
2019-09-24

Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA

David B Finlay, Samuel Banister, Michelle Glass
2019-10-01

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes

Dan Kho, Michelle Glass, Scott E. Graham, Natasha Grimsey
2019-01-30

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor

Natasha Grimsey, Michelle Glass
2019-05-08

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs

Samuel Banister, Richard C Kevin, Jamie J Manning, Marc Y Stevens, Iain McGregor, Michelle Glass, Mark A. Connor
2019-05-21

Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB1 receptors

Xiao Zhu, David B Finlay, Michelle Glass, Stephen Duffull
2018-02-19

An evaluation of the operational model when applied to quantify functional selectivity.

Michelle Glass, Xiao Zhu, David B Finlay, Stephen Duffull
2018-10-01

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA

Samuel Banister, Richard C Kevin, Michelle Glass, Mark A. Connor, Iain McGregor, Stephen Bright, Monica J. Barratt
2018

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines

Yurii Saroz, Michelle Glass, Natasha Grimsey
2018-10-23

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold

Caitlin R M Oyagawa, Sameek Singh, Sarah M. Hook, Natasha Grimsey, Michelle Glass, Joel D. A. Tyndall, Andrea J. Vernall
2017-01-03

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity

Pal Pacher, David B Finlay, Andrea Chicca, Jordyn M Stuart, Georgios Alachouzos, Marc P Baggelaar, Andrea Martella, Mark A. Connor, Mauro Maccarrone, Michelle Glass
2017-06-12

Is the Cannabinoid CB2 Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans?

Dan Kho, Michelle Glass, Scott E. Graham
2017-05-18

Gαs signalling of the CB1 receptor and the influence of receptor number.

Natasha Grimsey, Michelle Glass, David B Finlay, Morag R Hunter, Anisha Korde, V K Vemuri, Erin E Cawston
2017-11-28

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.

Michelle Glass, Sarah M. Hook
2017-06-27

Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP Signaling

David B Finlay, Natasha Grimsey, Michelle Glass
2016-06-07

Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model

Michelle Glass, Natasha Grimsey
2016-07-15

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

Shivani Sachdev, Marina Santiago, Jordyn M Stuart, Samuel Banister, Michelle Glass, Iain McGregor, Mark A. Connor, Michael Kassiou
2016-04-27

The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities

Samuel Banister, Michelle Glass, Michael Kassiou, Mark A. Connor
2016-02-22

One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors?

Karan Govindpani, Michelle Glass, Daniel Furkert
2016-03-21

GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine

David B Finlay, Natasha Grimsey, Michelle Glass
2015-05-08

Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

Samuel Banister, Jordyn M Stuart, Richard C Kevin, Michelle Glass, Mark A. Connor, Iain McGregor, Michael Kassiou
2015-07-02

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.

Samuel Banister, Jordyn M Stuart, Richard C Kevin, Michelle Glass, Mark A. Connor, Iain McGregor, Michael Kassiou
2015-09-23

Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors

Jordyn M Stuart, Natasha Grimsey, Michelle Glass, Mark A. Connor, William J Redmond, Erin E Cawston
2015-06-04

Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.

Michelle Glass, Patrick M. Sexton, Arthur Christopoulos, Elham Khajehali, Katherine Leach
2015-07-23

Distinct Temporal Fingerprint for Cyclic Adenosine Monophosphate (cAMP) Signaling of Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid Receptors.

Mark A. Connor, Vincenzo Di Marzo, Romano Silvestri, Michelle Glass
2015-01

Increasing the flexibility of the LANCE cAMP detection kit

Michelle Glass

Human - wd:Q39685216

Welcome to Inventaire

the library of your friends and communities

learn more